Fundraising Fox

M.H. Carnegie & Co.

Venture capital

Moore Park · Seed–Late Stage · 2 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

M.H. Carnegie & Co. is an Australian alternative asset investment manager that emphasizes alignment with investors through co-investment and performance-based overrides earned only after clients receive an adequate base return.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Late Stage
HQ
Moore Park, New South Wales, AU
Instruments
Equity
Founded
2010
AUM
$594M
Tracked investments
1

Team · 2 people

from public directories
Mark Carnegie· Founding Partnerin
Kate Thompson· Partnerin

What they invest in

from 1 of 1 portfolio companies

Biotech ×1Healthtech ×1Medical Devices ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path
Cardiac Dimensionscardiacdimensions.comin𝕏Mar 2025 · $53M

Cardiac Dimensions develops medical technology to treat heart failure caused by functional mitral regurgitation (FMR), aiming to address underlying causes rather than symptoms.

BiotechHealthtechMedical DevicesKirkland, US

Frederick A. Stewart(Executive Officer, Director)Rick Wypych(Executive Officer)

BoardKurt Wheeler(Director)Nathan Every(Director)Douglas C. Fisher(Director)Gerry Brunk(Director)

Co-investorsAPERTURE Venture PartnersLumira VenturesRedbus VenturesAlly Bridge GroupClaret Capital Partners

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does M.H. Carnegie & Co. invest at?
M.H. Carnegie & Co. invests at the Seed, Series A, Series B, Series C, Late Stage stages.
What sectors does M.H. Carnegie & Co. focus on?
M.H. Carnegie & Co. focuses on Crypto & Web3.
Where is M.H. Carnegie & Co. located?
M.H. Carnegie & Co. is headquartered in Moore Park, AU.

Images

M.H. Carnegie & Co. photo

Similar investors

Featured in lists